ES2139883T3 - MICROGRANULES OF 5-NITROIMIDAZOLE DERIVATIVES. - Google Patents

MICROGRANULES OF 5-NITROIMIDAZOLE DERIVATIVES.

Info

Publication number
ES2139883T3
ES2139883T3 ES95907683T ES95907683T ES2139883T3 ES 2139883 T3 ES2139883 T3 ES 2139883T3 ES 95907683 T ES95907683 T ES 95907683T ES 95907683 T ES95907683 T ES 95907683T ES 2139883 T3 ES2139883 T3 ES 2139883T3
Authority
ES
Spain
Prior art keywords
microgranules
medicinal
nitroimidazole derivatives
hand
gastrointestinal tract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95907683T
Other languages
Spanish (es)
Inventor
Gerard Leduc
Patrice Debregeas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
Ethypharm SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9400394A external-priority patent/FR2715067B1/en
Application filed by Ethypharm SAS filed Critical Ethypharm SAS
Application granted granted Critical
Publication of ES2139883T3 publication Critical patent/ES2139883T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Medicinal form contains a combination of microgranules of derivatives 5-nitroimidasole, consisting, on the one hand, of gastro-resistant microgranules and, on the other hand, of microgranules with a prolonged release of a medicinal agent. Gastroresistant microgranules are intended to guarantee the efficiency of the medicinal form of the present invention, primarily, in the upper part of gastrointestinal tract, while the microgranules with a prolonged medicinal agent release are operate mainly in the lower part of gastrointestinal tract.
ES95907683T 1994-01-14 1995-01-12 MICROGRANULES OF 5-NITROIMIDAZOLE DERIVATIVES. Expired - Lifetime ES2139883T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400394A FR2715067B1 (en) 1994-01-14 1994-01-14 New dosage form of 5-nitro-imidazole derivatives effective for the treatment of parasitic infections and infections of the entire gastrointestinal tract.

Publications (1)

Publication Number Publication Date
ES2139883T3 true ES2139883T3 (en) 2000-02-16

Family

ID=9459066

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95907683T Expired - Lifetime ES2139883T3 (en) 1994-01-14 1995-01-12 MICROGRANULES OF 5-NITROIMIDAZOLE DERIVATIVES.

Country Status (19)

Country Link
JP (1) JPH09507499A (en)
KR (1) KR100320140B1 (en)
CN (1) CN1088357C (en)
AT (1) ATE187068T1 (en)
AU (1) AU705570B2 (en)
BR (1) BR9506507A (en)
CZ (1) CZ286080B6 (en)
DE (1) DE69513632T2 (en)
DK (1) DK0739201T3 (en)
ES (1) ES2139883T3 (en)
MA (1) MA23429A1 (en)
MX (1) MX9602772A (en)
NZ (1) NZ279238A (en)
OA (1) OA10583A (en)
PL (1) PL178424B1 (en)
PT (1) PT739201E (en)
RU (1) RU2152212C1 (en)
SK (1) SK282066B6 (en)
UA (1) UA28031C2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4331930B2 (en) * 2001-10-17 2009-09-16 武田薬品工業株式会社 High content granules of acid labile drugs
RU2220711C1 (en) * 2002-04-24 2004-01-10 Закрытое акционерное общество "Брынцалов-А" Antibacterial and antiprotozoan agent "trihobrol"
KR20170052626A (en) 2014-09-05 2017-05-12 심바이오믹스 세러퓨틱스 엘엘씨 Secnidazole for use in the treatment of bacterial vaginosis
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346095A (en) * 1978-02-10 1982-08-24 Mercer James B Therapeutic treatment for viral hepatitis infection
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
DE3822095A1 (en) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
AU7909691A (en) * 1990-05-14 1991-12-10 Gary R. Jernberg Surgical implant and method incorporating chemotherapeutic agents
FR2692146B1 (en) * 1992-06-16 1995-06-02 Ethypharm Sa Stable compositions of gastro-protected omeprazole microgranules and process for obtaining them.

Also Published As

Publication number Publication date
BR9506507A (en) 1997-09-09
PL178424B1 (en) 2000-04-28
CZ205596A3 (en) 1996-10-16
SK282066B6 (en) 2001-10-08
AU1580395A (en) 1995-08-01
CN1138826A (en) 1996-12-25
KR100320140B1 (en) 2002-07-02
PT739201E (en) 2000-05-31
CN1088357C (en) 2002-07-31
PL315530A1 (en) 1996-11-12
CZ286080B6 (en) 2000-01-12
DK0739201T3 (en) 2000-05-01
RU2152212C1 (en) 2000-07-10
OA10583A (en) 2002-07-10
AU705570B2 (en) 1999-05-27
DE69513632D1 (en) 2000-01-05
NZ279238A (en) 1998-03-25
MA23429A1 (en) 1995-10-01
MX9602772A (en) 1997-05-31
DE69513632T2 (en) 2000-04-06
ATE187068T1 (en) 1999-12-15
UA28031C2 (en) 2000-10-16
JPH09507499A (en) 1997-07-29
SK91496A3 (en) 1996-12-04

Similar Documents

Publication Publication Date Title
TR199800602A3 (en) Dithiolan derivatives, their preparation and therapeutic effects.
MX9707334A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates.
ID21115A (en) ISOQUUOLOL-3-CARBOXAMIDE CHARACTERIZED, PRODUCTION AND USE AS A MEDICINE
FR15C0024I2 (en) 6-SUBSTITUTED INDOLINONES, THEIR PREPARATION AND THEIR USE AS MEDICINES
DE69829008D1 (en) Nose, mouth and throat cannula
DE50010677D1 (en) Novel aminodicarboxylic acid derivatives with pharmacological properties
DE69836514D1 (en) Electrode body, provided with this accumulator, and production of the electrode body and the accumulator
NO20014963L (en) Cycloalkyl-substituted benzimidazoles, as well as the preparation and use thereof
EE04236B1 (en) Benzimidazoles, their preparation and use as medicaments
LU91849I2 (en) Cimicoxib and its pharmaceutically acceptable derivatives - CIMALGEX®.
USD404097S (en) Practice bat
DE60023107D1 (en) PREPARATIONS WITH IMPROVED CONTROLLED RELEASE
DE69826684D1 (en) COVALENT-TIED N, O-CARBOXYMETHYLCHITOSAN AND ITS USE
IL126714A (en) Use of cells, organs or components thereof for the preparation of a pharmaceutical composition for establishing selective immune downregulation
ES2139883T3 (en) MICROGRANULES OF 5-NITROIMIDAZOLE DERIVATIVES.
ZA973016B (en) Transdermally administered acetylcysteine as mucolytic agent.
ZA976619B (en) Benzimidazole derivatives, their preparation and their therapeutic applications.
DE68906245D1 (en) THERAPEUTIC AGENT AGAINST AIDS.
RU96115480A (en) MEDICINAL PREPARED WITH CHOLOLYTOLITIC ACTION
BR9907195A (en) "prolonged-release tiagabine formulations with reduced side effects"
SK2502U (en) Envelope with delivery note
NL1013323A1 (en) Pantograph and coupling therefor.
MY128686A (en) Pharmaceutical composition containing selected lanthanum carbonate hydrates
AU132015S (en) Pants
TR28011A (en) Purified / pure streptogramin and its preparation.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 739201

Country of ref document: ES